Abdominal dropsy is one of the most frequently occurred complications of liver cirrhosis.Presently both domestic and foreign guidance for clinical practices recommend LVP as the preferred treatment for massive ascites

yet PPCD as one of the complications caused by LVP is prone to take place.To prevent this syndrome of complications

the current clinical practice often adopts the method of intravenous injection of human albumin which as a biological product has shortcomings such as high price and potential infection risks.As an artificially compounded vasopressin

terlipressin has seen years of clinical use and has assumed the role of replacing blood albumin as a preventive measure from PPCD.This article expatiates on the functioning mechanism and development of terlipressin in prevention of PPCD

and discuss about its safeness and the future research on it.